| 发明名称 |
Pyrrolotriazine kinase inhibitors |
| 摘要 |
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
|
| 申请公布号 |
US7534792(B2) |
申请公布日期 |
2009.05.19 |
| 申请号 |
US20070773466 |
申请日期 |
2007.07.05 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
WITTMAN MARK D.;MASTALERZ HAROLD;ZIMMERMANN KURT;SAULNIER MARK G.;VELAPARTHI UPENDER;VYAS DOLATRAI M.;ZHANG GUIFEN;JOHNSON WALTER LEWIS;FRENNESSON DAVID B.;SANG XIAOPENG;LIU PEIYING;LANGLEY DAVID R. |
| 分类号 |
C07D487/04;A61K31/53;A61P19/02;A61P35/00;C07D403/12;C07D403/14 |
主分类号 |
C07D487/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
